Lung function apparatus may be a source of cross infection in patients with cystic fibrosis and may be prevented using a 'bag in bottle' system. As this system has never been validated in children the flow volume loops performed using a Vitalograph Compact in the usual way were compared with results obtained blowing into the bag and bottle system, in random order, in 20 children with asthma (age 8-15 years). Three reproducible flow volume loops were recorded for each apparatus. There was no order effect. Mean (SE) results for forced expiratory volume in one second, forced vital capacity (FVC), peak expiratory flow rate, and maximum expiratory flow at between 75% and 25% of FVC showed respectively that the bag in bottle results were significantly greater than those obtained blowing directly into the spirometer by 90 (17) ml, 12*7 (5.1) /min, 130 (60) mlmin. Although statistically significant, these differences are within the previously described coefficients of variation for children with cystic fibrosis and are of doubtful clinical relevance. It is concluded that the bag in bottle system does not introduce any important systematic error. It potentially offers absolute protection from cross infection. (Arch Dis Child 1995; 72: 156-158) 
The apparatus in use. The child blows into the plastic bag, which is confined within the rigid Perspex box. The box is connected to the Vitalograph Compact.
There are growing concerns about cross infection particularly with Pseudomonas cepacia, but also with methicillin resistant Staphylococcus aureus between patients with cystic fibrosis.'
Contamination of lung function apparatus by P cepacia has been described,' and may be one way whereby this pathogen is transmitted from one patient to another.1 2 We routinely perform flow volume curves using the Vitalograph Compact on all patients over 5 years of age when they attend our cystic fibrosis clinic. To get optimum readings it is vital that the patient breathes out as hard and as long as possible into the mouthpiece. It is often difficult for children to coordinate their breathing enough to remove the mouthpiece before breathing in again, and therefore some inspire from the body of the spirometer into which other cystic fibrosis patients will have just blown.
Our previous work has shown that the risk of cross contamination through lung function apparatus is small.3 However, we felt that with the anxiety over cross infection with P cepacia4 5 it was preferable completely to eliminate any risk. A disposable 'bag in bottle' spirometry system has been in use in our hospital lung function department for five years6 but never validated in children nor used in a routine outpatient setting. The purpose of this study was to determine whether the use of this system significantly affects the results of spirometry in children.
Patients and methods

STUDY 1
Calibrations were performed using a three litre syringe. The spirometer used was the Vitalograph Compact in use routinely in our clinic. Ten calibrations were performed placing the syringe in the flow head in the usual way, and 10 using the bag in bottle system. STUDY 2 We recruited 20 children (five girls) from the paediatric asthma clinic; their age range was 8-15 years. Asthma had been diagnosed on standard criteria.7 Informed consent was given by all children and their parents. All children had performed flow volume loops many times previously. The spirometer was calibrated with a three litre syringe before and after each child had been studied. The bag in bottle system was supplied by P K Morgan (Chatham, Kent). A disposable mouthpiece was attached to a plastic connection that way that there were minor improvements in performance. The absolute values of the overestimates were however small (of the order of 5%), which is well within the coefficient of variation of both normals and children with cystic fibrosis,8 9 and is unlikely to introduce significant errors into clinical practice. The cost of introducing this system is £575 for the apparatus with the plastic pieces holding the mouthpiece costing a further £64, and £2 for 50 disposable bags. By comparison, filtered mouthpieces (Vitalograph) cost £24.80 for 200.
Thus the use of the bag in bottle system saves £8.80 per 100 examinations, at a cost of an initial outlay of £639. We know of no published research on the protective effects (if any) of these filters. The alternative is to take no precautions at all, and ask children not to breathe in from the apparatus. In our experience, some children inspire despite the most careful instructions. The clinical importance of this is not known, but even a small risk should not be taken unnecessarily.
Subsequent to performing this study, we have introduced the bag in bottle system into our cystic fibrosis clinic. We have performed more than 500 tests using this equipment over the past 12 months. Delays are minimal, and no patient has refused to use it. Such infection precautions are probably not necessary in an asthma clinic if the risk of methicillin resistant S aureus is low. However, in a cystic fibrosis clinic, although the risk of cross infection is probably very low, we suggest that this simple technique should become routine in view of the potentially catastrophic consequences of P cepacia and methicillin resistant S aureus.
